OTC: Why Not Ivermectin?

New proposed legislation, SB601, would allow for over-the-counter access to ivermectin. This bill is sponsored by Senator Mastriano and is currently in the Consumer Protection & Professional Licensure Committee (CPPL). It’s time to get on the phone and call Senator Stefano, chair of the committee, so that we can get this bill moving forward!

You can reach Senator Stefano at: (717) 787-7175. Don’t forget— it’s okay to leave a message after hours. Here’s a simple suggested message:

Hello, my name is [First and Last Name] and as a PA resident, I’m calling to ask Senator Stefano to please move the Ivermectin bill SB610 out of the CPPL committee because [Key Talking Point]. Thank you and if you have any questions feel free to reach me at [phone number].

Why we support this bill: Medical freedom means the right to access and use health products without unnecessary barriers or gatekeepers. This includes the ability to purchase over-the-counter medications, especially when they are affordable, have a long history of safe use, and are available globally without prescription. SB610 promotes this by allowing Pennsylvanians to obtain ivermectin without a prescription or medical consultation, reinforcing the individual’s right to make informed health decisions for themselves and their families.

Key Talking Points for Bill Promotion:

1. Global Access Standards: Ivermectin is sold over-the-counter in several U.S. states and many countries. Pennsylvania residents deserve the same level of access as citizens elsewhere.

2. Affordability & Autonomy: Over-the-counter status can significantly reduce cost by removing the need for insurance, co-pays, and doctor visits—barriers that especially affect low-income families.

3. Decentralizing Health Control: This bill shifts decision-making power from institutions to individuals, aligning directly with PCIC’s mission to preserve autonomy and resist centralized medical mandates.

4. Slippery Slope Prevention: If basic medications can be withheld or restricted, it opens the door for future limitations on natural supplements, alternative therapies, or even dietary products.

Why Is Access Currently Being Denied?

1. It’s not about safety. Ivermectin has one of the best safety profiles of any medication on the market.

2. No Profit Motive: As a generic, low-cost drug, no company stands to make billions from it. That means no lobbyists are pushing for its release.

3. Control Over Health Decisions: Making ivermectin OTC would empower individuals to take their health into their own hands—something certain institutions resist.

4. Fear of Unapproved Uses: While off-label use happens with many prescription drugs, ivermectin became controversial during the COVID era. That doesn’t justify restricting access for the thousands who use it safely and appropriately for FDA-approved conditions.

PCIC Lobby Days typically run 10am – 2pm. No experience necessary! For more details, go HERE.

Having trouble viewing this email?

View this email in your browser